The low-trau matic method of photodynamic ther apy (PDT) has been re cently used for the treat ment of malig nant neoplasms. Ac cord ing to this method an or ganism with tu mor is treated by photosensibilizators, which are ac cu mu lated in ma lig nant cells mak ing them light-sen si tive. Hence, the fol low ing ir ra di a tion can selec tively ruin the tu mor cells. This method pro vides higher in dam ag ing tu mor cells se lec tiv ity com par ing to the meth ods of ra dio ther apy and che mo ther apy. This se lec tiv ity can be ex plained by higher ac cu mu la tion and pro longed stor age of photosensibilizator in tu mor cells in com par i son with nor mal tis sues. How ever, it does not pro vide very high per cent age of photosensibilizator cu mu lat ing in tu mors be cause these com pounds can be also ac cu mu lated by nor mal tis sues. Be cause photosensibilizators had no sat is factory se lec tiv ity in ac cu mu la tion by tu mor cells, the inves ti ga tors made an at tempt to find some new approaches for PDT that at least provide effective photosensibilizator targeting to malignant tissues.
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New D. et al [1] made the first step in this di rec tion. They showed that con ju gates of hematoporphyrin chem i cally cou pled with an ti bod ies to spe cific sur face tu mor an ti gens were pref er en tially ac cu mu lated in tumor cells. This in ves ti ga tion opened a way for the target photodynamic ther apy, when not only an ti bod ies [2] but also cytokines [8] , growth fac tors and their recep tors, etc [9] [10] [11] [12] [13] could be used for targeting.
In re cent years the antivascular ef fect of PDT has been in ten sively in ves ti gated [14] .This re search was di rected on both the screen ing of new photosensibilizators, af fect ing the tu mor vas cu lar system, and ef fec tive photosensibilizator de liv ery to the ves sels ac tively formed in a tu mor. One of the per spective meth ods of such se lec tive de liv ery is in tro duc tion of photosensibilizators in the form of con ju gates with angiogenesis in duc ers and antibodies against them.
Ma te ri als and meth ods. Polyclonal an ti bod ies directed against VEGF were ob tained by rab bit im mu niza tion us ing a method of in duc tion of lo cal im mune reac tion of the lymph nodes by low dose an ti gen with Freund's adjuvant [15] .
To ob tain an ti bod ies the murine angiogenic fac tor was pre pared as de scribed in [16] . Hematoporphyrin was used as a porphyrin com pound of hematoporphyrin-dihydrochloride con ju gate (Sigma, USA). Carbodiimide-HCL was used as a linker for the men tioned con ju gate.
Con ju gates of an ti bod ies with porphyrin compounds were ob tained ac cord ing to the fol low ing scheme [1] : 20g of hematoporphyrin was di luted in 3 ml of the sol vent (wa ter: dimethyl formamide, 2.5:0.5). 20 mg of 1-ethyl-3-(3-dimethylaminopropil)-dimethylcarbodiimide di luted in 0.5ml of wa ter was added to the porphyrin so lu tion. The so lu tions of hematoporphyrin and linker were mixed and stayed at room tem per a ture for 30 min. Af ter re ac tion 900 mg of an ti bod ies di luted in 5 ml of buf fered phos phate so lution, pH 7.2 was added to an ac tive hematoporphyrin -linker com plex. The ob tained mix ture stayed for 5 hours with pe ri od i cal stir ring. Dur ing this pro ce dure pH of the mix ture was ad justed to 6.0-7.0. To stop the re ac tion 50µl of monoethanolamine was added at the end of the incubation period (5hours).
The mix ture was left at room tem per a ture for 12 hours and then di a lyzed against the so lu tion of wa ter: dimethyl sulfoxide, 2.5:0.5, for 72 hours, the di al y sis so lu tion be ing pe ri od i cally changed. Af ter di al y sis the ob tained con ju gate was lyophilized. Ab sorp tion spectrum was reg is tered us ing Nano Drop spectrophotometer, USA.
Immunoconjugate phototoxicity was de ter mined in the model of photoinduced eryth ro cyte haemolysis due to hematoporphyrin ac tiv ity of the com plex [1] . Blood of healthy rats was washed three times in phys i o log i cal so lu tion and PBS, ra tio 1:5. Af ter wash ing the eryth rocyte frac tion was cen tri fuged at 500g for 5min. The pel let was di luted in PBS, 1:20(vol ume/vol ume). Each probe con tains 200 µl of the di luted eryth ro cyte suspen sion and 150 µl of PBS. Ex per i men tal probes contain 50 µl of the in ves ti gated con ju gate. Con trol probes con tain 50 µl of hematoporphyrin stock so lu tion (20 mg of hematoporphyrin was di luted in 3 ml of the mixture wa ter:dimethyl formamide, 2.5:0.5). To de ter mine photosensibilizator dark ac tiv ity some of the ex per imen tal and con trol probes were kept in the dark ness. Ex per i men tal probes were ir ra di ated by the or di nary illu mi na tor, light in ten sity till 1.5mWt per cm 2 for 5 min with pe ri od i cal stir ring. Af ter ir ra di a tion the sam ples were cen tri fuged at 500g for 5min. 100 µl of the supernatant were added to 900 µl of Drobkin re agent (test-sys tem for quan ti ta tive he mo glo bin de ter mi nation). The amount of he mo glo bin, which was re leased as a re sult of eryth ro cyte dam age by hematoporphyrin, was mea sured with spectrophotometer at 540 nm. A calibration curve was made according to the test-system instruction.
A spe cific ac tiv ity of anti-VEGF an ti bod ies in their con ju gates with porphyrin com pounds ( one of the main char ac ter is tics of the ob tained com plex) was es timated by ELISA with VEGF as an an ti gen [15] . The an ti gen was ad sorbed on the plate, 10ng per well.
The level of con ju gate ac cu mu la tion in the neo-angiogenesis zone was an a lyzed on the chicken em bryo chorioallantoic mem brane. Photosensibilizators (2mg per kg) were in jected into allantois of em bryo at 6 th and 10 th day of the de vel opment [17] . In 24 hours af ter photosensibilizator in jection, when hematoporphyrin was in jected to con trol group and con ju gate with VEGF an ti bod ies to ex per imen tal one, chorioallantoic mem branes were ex tracted, ho mog e nized in 0.1M NaOH (3ml/0.5g of tis sue) and cen tri fuged at 15,000g for 20min. The con tent of photosensibilizator agent, hematoporphyrin, was deter mined in the supernatants by the spectrophotometer method at 505 nm.
Re sults and Dis cus sion. The ab sorp tion spec tra of the in ves ti gated con ju gate did not re veal any es sen tial changes in ab sorp tion of both: porphyrin and pro tein com po nent of the com plex as com pared with the absorp tion spec tra of the mi nor com po nent i.e. hematoporphyrin (see Fig.1 ). It is known that porphyrin com pounds can ab sorb at 390-600nm with the ab sorp tion peak at 505nm. The spec trum has 4 lines, one of which, Sare line is a char ac ter is tic fea ture of the porphyrin com pounds. The con ju gates ob tained had the same ab sorp tion re gion of 390-600nm with Sare line also pres ent. Ac cord ing to the com par i son of spec tra no es sen tial changes were found in phys i cal prop er ties of porphyrin com pound of the con ju gate and hematoporphyrin it self. The pro tein com po nent of the conjugate, i.e. antibody, did not seem to change either.
In full ab sorp tion spec trum, 190-690nm, we could ob serve con stant ab sorp tion peak at 260nm, which is an ex act pro tein char ac ter is tic. There fore, the con jugate com posed of hematoporphyrin photosensibilizator and polyclonal an ti bod ies to EGF prac ti cally does not lose the ab sorp tion prop er ties of the orig i nal com po nents i.e. an ti bod ies and hematoporphyrin.
Mo lar ra tio of hematoporphyrin and an ti bod ies equal to 4.2 was de ter mined by ab sorp tion at 505 and 280nm cor re spond ingly.
In ves ti gat ing the immunoconjugate phototoxicity we found that equiv a lent amount of the con ju gate and orig i nal photosensibilizator, hematoporphyrin had the same ac tiv ity in eryth ro cyte haemolysis (Fig.2) . Notewor thy, that in the probes, which stayed in the darkness, the eryth ro cyte haemolysis re ac tion was not observed. It can ev i dence, that the con ju gate does not possess dark phototoxicity.
Spe cific an ti body ac tiv ity in the con ju gates with porphyrin com pounds is one of the main char ac ter is tic of such com plexes. The in ves ti ga tion showed that the con ju gate for ma tion be tween hematoporphyrin with VEGF an ti bod ies us ing carbodiimide as a linker made in flu enced es sen tially on the spe cific an ti body ac tiv ity in the con ju gates. The ti ter of these an ti bod ies in the ELISA an ti gen-an ti body test was 12,800 that are twice less than the ti ter non-conjugated antibodies -25,600 (Fig.3) .
The study on spe cific con ju gate ac cu mu la tion in neoangiogenesis zones of chicken em bryo showed an es sen tial dif fer ence in the ac cu mu la tion of photoactive com pound by the vas cu lar sys tem of chorioallantoic mem brane on the 6 th and 10 th day of the de vel op ment (Fig.4) .
It is known, that on the 6 th day the chorioallantoic mem brane of the em bryo is char ac ter ized by max i mal en do the lium pro lif er a tion and cap il lary for ma tion. How ever on the 10 th day of the de vel op ment we could no tice sta bi li za tion of neovascular pro cesses in membranes. In 24 hours af ter the con ju gate in jec tion the differ ent level of photosensibilizator ac cu mu la tion could be ob served in the chorioallantoic mem branes. On the th day of the em bryo de vel op ment it was ac cu mu lated in 2.5 times more hematoporphyrin con ju gated with VEGF an ti bod ies in com par i son with the em bryo of the 10 th day of the de vel op ment. Be cause the lat ter is charac ter ized by the sta bi li za tion of neovascular pro cesses, these data de noted vasotropic ef fect in the way of photosensibilizator ac cu mu la tion. It hap pened as a result of photosensibilizator tar get ing im me di ately into the zones of ac tive angiogenesis. The chorioallantoic mem branes on the 6 th day of the development just may be considered as such zones.
The sense of PDT is in tro duc tion of photosensibilizators into an or gan ism con tain ing tu mor for their se lec tive ac cu mu la tion by tu mor cells. However, the photosensibilizators, which are cur rently used in on col ogy, do not pos ses such se lec tiv ity. There is a real way to make them se lec tive: to cre ate con ju gates on the base of photoactive com pounds and bi o log i cally ac tive sub stances. These con ju gates should pro vide target ing of photosensibilizators to wards tu mor cells. The tu mor vas cu lar sys tem could be an efficient target for such purpose.
Our study on the chorioallantoic mem branes of chicken em bryo has shown that the photoactive con jugate of hematoporphyrin with VEGF an ti bod ies is able to ac cu mu late just in the zones of ac tive de vel op ment of cap il lary net in em bryo mem branes. Af ter neo-angiogenesis sta bi li za tion (10 th day of the em bryo de vel op ment) the ac cu mu la tion of photoactive con jugate by mem branes was sharply de creased. Tak ing into con sid er ation these re sults we can state that the obtained con ju gated photosensibilizator has vasotropic prop er ties. This al lows us to de velop the method to provide photodynamic tar get ing ac tion on the neo plasm vas cu lar sys tem through angiogenically ac ti vated endo the lial cells, which take part in the for ma tion of neovascularization zones during the tumor development, further growth and metastasis.
The pref er ence of en do the lial cells as tar gets for tumor treat ment can be ex plained by the ex pres sion on The ap pli ca tion of such vari ant of tar get ing PDT could strengthen the photodynamic anti-tu mor ef fect while de creas ing the dos age of the in jected photosensibilizators and low er ing the level of their toxicity.
Con clu sions. 1. The photoactive bioconjugate of VEGF an ti bod ies with photosensibilizator, hematoporphyrin, has been ob tained.
2. The con ju gate prac ti cally does not lose phys i cal and bi o log i cal prop er ties, which are char ac ter is tic of its pro tein com po nent, an ti bod ies, and its porphyrin compo nent, hematoporphyrin.
3. It has been shown that the con ju gate ac cu mu lation in the chorioallantoic mem branes of chicken embryo with the max i mal en do the lium pro lif er a tion (on the 6 th day of the em bryo de vel op ment) was 2.5 times higher in com par i son with the em bryo mem branes on the 10 th day of the de vel op ment i.e. the pe riod of sta bi liza tion of neo-vascular processes . 
